Filing Details

Accession Number:
0001209191-18-040955
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-03 16:09:54
Reporting Period:
2018-06-30
Accepted Time:
2018-07-03 16:09:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
897448 Amarin Corp Plc AMRN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1408920 T Joseph Kennedy C/O Amarin Pharma, Inc.
1430 Route 206
Bedminster NJ 07921
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-06-30 47,187 $0.00 65,621 No 4 M Direct
Ordinary Shares Acquisiton 2018-06-30 6,250 $0.00 71,871 No 4 M Direct
Ordinary Shares Disposition 2018-06-30 26,495 $3.09 45,376 No 4 F Direct
Ordinary Shares Disposition 2018-07-02 26,942 $3.00 18,434 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Restricted Stock Units Disposition 2018-06-30 47,187 $0.00 47,187 $0.00
Ordinary Shares Restricted Stock Units Disposition 2018-06-30 6,250 $0.00 6,250 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
188,750 No 4 M Direct
25,000 No 4 M Direct
Footnotes
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  2. As previously reported on July 8, 2015, the Reporting Person was granted 755,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in 16 equal quarterly installments. The twelfth vesting event occurred on June 30, 2018.
  3. Not applicable.
  4. Please see the section titled "Remarks" below for additional information.
  5. As previously reported on October 6, 2015, the Reporting Person was granted 100,000 RSUs under the Plan. These RSUs vest in 16 equal quarterly installments. The twelfth vesting event occurred on June 30, 2018.
  6. Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
  7. Sales made pursuant to a 10b5-1 trading plan dated December 9, 2016.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.92 to $3.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  9. Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.